Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

   417,826      
Direct Value   $6,163,557    

Indirect Value

   $16,623,289      
Total Shares   592,616      
Total Value   $22,786,845      


Agios Pharmaceuticals Inc $5,419,090 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,556 Denali Therapeutics Inc. $445,612 Regeneron Pharmaceuticals Inc $292,299 Agios Pharmaceuticals Inc $5,419,090 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,556 Denali Therapeutics Inc. $445,612 Regeneron Pharmaceuticals Inc $292,299
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 118.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-02-16 4 AS $50.01 $300,060 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-06 4 AS $50.02 $55,022 D/D (1,100) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-07 4 AS $50.02 $95,038 D/D (1,900) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-05-01 4 AS $50.06 $150,180 D/D (3,000) 0 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-11-04 4 AS $50.18 $501,830 D/D (10,000) 65,000 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-07-03 4 AS $51.18 $153,540 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2020-02-18 4 D $52.01 $131,793 D/D (2,534) 103,158 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-01 4 AS $55.12 $165,360 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2019-02-19 4 D $58.03 $143,392 D/D (2,471) 89,503 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-04-03 4 AS $58.62 $175,860 D/D (3,000) 0 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-11-10 4 AS $60.03 $600,310 D/D (10,000) 55,000 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-10-01 4 AS $60.07 $780,910 I/I (13,000) 131,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 AS $60.55 $1,453,200 D/D (24,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-12-01 4 AS $61.51 $369,288 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-01 4 AS $62.20 $373,200 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 AS $62.68 $3,760,800 I/I (60,000) 137,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-11-01 4 AS $63.32 $383,105 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-02 4 AS $66.76 $400,560 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 AS $67.12 $2,349,200 D/D (35,000) 0 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-11-12 4 AS $70.05 $2,101,590 D/D (30,000) 25,000 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 AS $70.14 $5,611,200 D/D (80,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 AS $71.77 $3,877,218 D/D (53,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-04-02 4 AS $75.54 $1,010,357 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-02-01 4 AS $78.50 $1,023,756 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 AS $80.01 $2,630,329 D/D (32,875) 0 0 -
  154  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us